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Abstract: Re-investigation of the 1H-NMR spectrum reported for 15-bromo-4-oxa-2,9-
diaza-1(2,4)-pyrimidine-3(1,3)-benzenacyclononaphane (2) prepared via a Mitsunobu- 
mediated macroether cyclisation led to a proposed structural isomer (3). The title compound 
(3) was prepared via a two-step protocol and assigned using 1H, 13C-NMR and LC-MS.  
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Macrocycles are an important class of organic compounds defined as containing cyclic systems of 12 
or more atoms [1]. Macrocycles have garnered much attention recently in medicinal chemistry due to 
their ability to access biologically relevant conformations [2–4]. There are a variety of macrocyclisation 
strategies available [5] in particular we were interested in the intra-molecular Mitsunobu reaction that 
has been used to prepare kinase inhibitor scaffolds [6,7]. Lücking et al. [8] have reported a high dilution 
intra-molecular Mitsunobu reaction to macrocycle 2 (Scheme 1) that possessed micromolar activity 
against CDK2 and anti-proliferative effects towards MCF7 cells. We were intrigued by the stated  
1H-NMR spectrum for 2 which showed the four methylene groups occurred at 3.30 ppm (m, 4H) and 
1.90 ppm (m, 4H). We therefore considered whether there is a choice of two intra-molecular Mitsunobu 
reactions—one that delivers compound 2 and one that delivers compound 3. To address this question we 
prepared the novel isomer, 3. 
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Scheme 1. Lücking et al. [8] route to macrocyclic scaffold 2 and our postulated isomer 3. 
Our synthesis of 3 (Scheme 2) commenced with pyrrolidine mediated displacement of the more 
reactive C-Cl bond in 4 which afforded 5 in modest yield after trituration. The synthesis of 3 was 
accomplished using an analogous SNAr procedure to that reported by Lücking et al. [8]. Chromatographic 
separation and trituration afforded a sample of 3 in modest yield under identical elution conditions.  
1H and 13C NMR spectra of intermediate 5 and product 3 are provided in the supplementary materials. 
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Scheme 2. Synthetic route to 3. 
Interestingly, the 1H-NMR spectrum obtained for 3 matches the signals reported [8] for 2 for all the 
aryl and exchangeable protons. Two sets of multiplets consisting of 4 protons each was observed for 3. 
However, the symmetrical methylene peaks adjacent to the nitrogen occurred further downfield at  
3.75–3.70 ppm (m, 4 H) versus the 3.30 ppm (m, 4H) reported for 2 [9]. In conclusion, we have prepared 
a novel structural isomer 3 of compound 2.  
Experimental Section 
General Information 
Reactions were carried out under argon. Organic solutions were dried over Na2SO4. Starting materials 
and solvents were purchased from commercial suppliers and were used without further purification. 
Flash silica chromatography was performed using Merck silica gel 60 (0.025–0.04 mm). 1H and  
13C-NMR spectra were recorded using a JEOL ECS 400 NMR Spectrometer. Chemical shifts (δ) are 
reported relative to TMS (δ = 0) and/or referenced to the solvent in which they were measured.  
High-resolution mass spectrometry analysis was performed on an Agilent 6450 LC-MS/MS. 
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Synthesis of 3-((5-Bromo-4-(pyrrolidin-1-yl)pyrimidin-2-yl)amino)phenol (3) 
Triethylamine (1.0 mL, 7.3 mmol) and pyrrolidine (0.55 mL, 6.6 mmol) are added to a stirred solution 
of 5-bromo-2,4-dichloropyrimidine (4) (0.84 mL, 6.6 mmol) in acetonitrile (6 mL). The reaction mixture 
was stirred at room temperature overnight. After 12 h, the precipitate that formed was filtered off. The 
filtrate was concentrated in vacuo and triturated with isopropyl ether. 5-Bromo-2-chloro-4-(pyrrolidin-
1-yl)pyrimidine (5) was obtained, 0.67 g (2.5 mmol, 38%) [10]. HCl (4 M in dioxane, 0.12 mL) is added 
to 3-aminophenol (53 mg, 0.49 mmol) and 5-Bromo-2-chloro-4-(pyrrolidin-1-yl)pyrimidine (5) (132 mg, 
0.51 mmol) in acetonitrile (1.5 mL), and the reaction mixture was stirred at reflux for 12 h. After cooling 
to room temperature, the reaction mixture is concentrated in vacuo. Water (1.0 mL) was added, and the 
organic layer extracted with ethyl acetate (5 mL × 2). The combined organic phases were dried (Na2SO4), 
filtered, and concentrated in vacuo. The residue was purified by silica gel chromatography 
(dichloromethane/methanol; 9:1), and the crude product obtained was triturated with isopropyl ether. 
The title compound 3 was obtained as a white powder, 44 mg (0.13 mmol, 27%).  
1H-NMR (400 MHz, d6-DMSO) δ 9.20 (s, 1H), 9.10 (s, 1H), 8.03 (s, 1H), 7.23–7.21 (m, 1H), 7.12–7.09 
(m, 1H), 6.99 (dd, J = 7.8 Hz, 1H), 6.33–6.29 (m, 1H), 3.75–3.70 (m, 4H), 1.89–1.84 (m, 4H). 
13C-NMR (100 MHz, d6-DMSO) δ 159.0, 157.4, 156.9, 141.8, 128.9, 109.6, 108.2, 105.7, 90.1, 49.5, 25.1. 
LC-MS (TOF, 2.0 min) Rt = 0.243 min; m/z (ESI) 335 (M79Br+H), 337 (M81Br+H).  
Hi-Res LC-MS (ESI) m/z calcd for C14H1679BrN4O (M+H) 335.0507, found 335.0477. 
Melting point range: 159–160 °C. 
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